Engineering receptors activated solely by synthetic ligands (RASSLs)

Trends in Pharmacological Sciences

Volumn 22, Issue 8, 2001, Pages 414-420

  Scearce Levie, Kimberly ^a   Coward, Peter ^a   Redfern, Charles H ^a   Conklin, Bruce R ^a  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAM 12 P; CALCIUM; DELTA OPIATE RECEPTOR; DOXYCYCLINE; DYNORPHIN[1-13]; EPITOPE; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR; LIGAND; PEPTIDE; RECEPTOR ACTIVITY MODIFYING PROTEIN; SPIRADOLINE;

CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CARDIOMYOPATHY; COGNITION; GENE EXPRESSION; HEART; HUMAN; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR SENSITIVITY; REVIEW; SENSORY SYSTEM; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

ANALGESICS; ANIMALS; HEART RATE; HUMANS; MICE; MICE, TRANSGENIC; PYRROLIDINES; RECEPTORS, CELL SURFACE; RECEPTORS, OPIOID, KAPPA; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TECHNOLOGY, PHARMACEUTICAL;

EID: 0035423643     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01743-0     Document Type: Review

References (34)

1. Structure and function of G protein-coupled receptors
2. Receptor-effector coupling by G proteins: Implications for normal and abnormal signal transduction
3. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
4. i-coupled receptor
5. i-coupled receptor in transgenic mice
6. i-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy
7. Unnatural ligands for engineered proteins: New tools for chemical genetics
8. Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization
9. Allele-specific activation of genetically engineered receptors
10. 2-adrenergic receptor
11. The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist
12. Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans
13. κ-Opioid receptors and analgesia
14. The third extracellular loop of the μ opioid receptor is important for agonist selectivity
15. The third extracellular loop of the human δ-opioid receptor determines the selectivity of δ-opioid agonists
16. Agonists and antagonists bind to different domains of the cloned κ opioid receptor
17. Mapping the receptor domains critical for the binding selectivity of δ-opioid receptor ligands
18. Analysis of selective binding epitopes for the κ-opioid receptor antagonist nor-binaltorphimine
19. i-coupled receptors
20. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
21. Conditional transgene expression in the heart
22. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice
23. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen
24. Control of memory formation through regulated expression of a CaMKII transgene
25. Transgenic animals with inducible, targeted gene expression in brain
26. G proteins in the heart: A redundant and diverse transmembrane signaling network
27. Tissue distribution of opioid receptor gene expression in the rat
28. Synthesis of functional human hemoglobin in transgenic mice
29. B receptor binding in thalamus of a genetically prone rat (GAERS)
30. s-induced neurodegeneration in Caenorhabditis elegans
31. 2 dopamine receptor missense variants
32. B receptors make it to the top - As dimers
33. Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the β1-adrenergic receptor
34. 7TM receptors: The splicing on the cake